Endobronchial blocker use for massive, focal pulmonary hemorrhage during pulmonary endarterectomy for CTEPH

J Heart Lung Transplant. 2022 Aug;41(8):1130-1133. doi: 10.1016/j.healun.2022.04.006. Epub 2022 Apr 27.


Chronic thromboembolic pulmonary hypertension (CTEPH) has a poor prognosis if left untreated but can be cured by pulmonary endarterectomy (PEA). Massive endobronchial pulmonary hemorrhage is a potentially fatal complication of PEA, occurring in 0.5%of patients. We describe the use of an endobronchial blocker (EBB) as an additional method to successfully treat massive, focal pulmonary hemorrhage during PEA.

Keywords: chronic thromboembolic pulmonary hypertension; endobronchial blocker; pulmonary endarterectomy; pulmonary hemorrhage; veno-arterial (VA)-ECMO.

Publication types

  • Editorial

MeSH terms

  • Chronic Disease
  • Endarterectomy / methods
  • Extracorporeal Membrane Oxygenation* / methods
  • Hemorrhage / etiology
  • Hemorrhage / surgery
  • Humans
  • Hypertension, Pulmonary* / complications
  • Hypertension, Pulmonary* / surgery
  • Infant, Newborn
  • Pulmonary Artery / surgery
  • Pulmonary Embolism* / complications
  • Pulmonary Embolism* / surgery
  • Treatment Outcome